Science & Technology
Title: Developing a novel drug for neurobehavioral deficits in FASD
Department of Health and Human Services — National Institutes of Health
Opportunity #: 2R42AA029025-02
Award Ceiling
$1.1M
Award Floor
$1.1M
Close Date
Aug 31, 2027
534 days leftTotal Funding
$1.1M
Expected Awards
1
Posted Date
Sep 20, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-2R42AA029025-02
Description
STTR Phase Phase II award: "Title: Developing a novel drug for neurobehavioral deficits in FASD" awarded to COGTHERA LLC in BROOKEVILLE, Maryland. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $1,077,312. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.